Cargando…

Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant

AIMS: Since the first description of the classical presentation of progressive supranuclear palsy (PSP) in 1963, now known as Richardson's syndrome (PSP-RS), several distinct clinical syndromes have been associated with PSP-tau pathology. Like other neurodegenerative disorders, the severity and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ling, H, de Silva, R, Massey, L A, Courtney, R, Hondhamuni, G, Bajaj, N, Lowe, J, Holton, J L, Lees, A, Revesz, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260147/ https://www.ncbi.nlm.nih.gov/pubmed/23432126 http://dx.doi.org/10.1111/nan.12037

Ejemplares similares

Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Jabbari, Edwin, et al.
Publicado: (2020)

Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options
por: Lamb, Ruth, et al.
Publicado: (2016)

Language impairment in progressive supranuclear palsy and corticobasal syndrome
por: Peterson, Katie A., et al.
Publicado: (2019)

Caregiver strain in progressive supranuclear palsy and corticobasal syndromes
por: Kellermair, Lukas, et al.
Publicado: (2021)

Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy
por: Tse, Nga Yan, et al.
Publicado: (2020)

MAPT ‐Associated Familial Progressive Supranuclear Palsy with Typical Corticobasal Degeneration Neuropathology: A Clinicopathological Report
por: Cullinane, Patrick W., et al.
Publicado: (2023)

Systematic Review of Prevalence Studies of Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Swallow, Diane M.A., et al.
Publicado: (2022)

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2015)

Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome
por: Whiteside, David J., et al.
Publicado: (2023)

Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer
por: Ling, Helen, et al.
Publicado: (2014)

A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome
por: Chung, Eun Joo, et al.
Publicado: (2022)

The genetic and clinico‐pathological profile of early‐onset progressive supranuclear palsy
por: Jabbari, Edwin, et al.
Publicado: (2019)

Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Bharti, Komal, et al.
Publicado: (2017)

The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
por: Dodich, Alessandra, et al.
Publicado: (2019)

Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers
por: Parmera, Jacy Bezerra, et al.
Publicado: (2022)

Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures
por: Valentino, Rebecca R., et al.
Publicado: (2020)

Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2020)

Migraine and Tension-type Headache in Parkinson's Disease and Progressive Supranuclear Palsy/Corticobasal Syndrome
por: Jatale, Vinayak, et al.
Publicado: (2023)

Machine learning‐based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration
por: Koga, Shunsuke, et al.
Publicado: (2021)

The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis
por: Lyons, Shane, et al.
Publicado: (2023)

Fiber-specific micro- and macroscopic white matter alterations in progressive supranuclear palsy and corticobasal syndrome
por: Uchida, Wataru, et al.
Publicado: (2023)

Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study
por: Zhang, Yu, et al.
Publicado: (2016)

Towards accurate and unbiased imaging-based differentiation of Parkinson’s disease, progressive supranuclear palsy and corticobasal syndrome
por: Correia, Marta M, et al.
Publicado: (2020)

Language Disorder in Progressive Supranuclear Palsy and Corticobasal Syndrome: Neural Correlates and Detection by the MLSE Screening Tool
por: Peterson, Katie A., et al.
Publicado: (2021)

Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
por: Katzdobler, Sabrina, et al.
Publicado: (2022)

Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2022)

Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration
por: Koga, Shunsuke, et al.
Publicado: (2023)

Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
por: Illán-Gala, Ignacio, et al.
Publicado: (2022)

Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants
por: Whitwell, Jennifer L., et al.
Publicado: (2019)

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
por: Bluett, Brent, et al.
Publicado: (2021)

Distinct subcortical tau burden: The tau pallido‐claustral ratio separates progressive supranuclear palsy and corticobasal degeneration
por: Zhao, Chelsey ShengQi, et al.
Publicado: (2021)

Presence of Skin α-Synuclein Deposits Discriminates Parkinson’s Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Giannoccaro, Maria Pia, et al.
Publicado: (2022)

Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype
por: Jabbari, Edwin, et al.
Publicado: (2018)

Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn)
por: Saito, Yuya, et al.
Publicado: (2022)

Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy
por: Höglinger, Günter U., et al.
Publicado: (2011)

Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy
por: Ferrari, Raffaele, et al.
Publicado: (2014)

Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy
por: Sintini, Irene, et al.
Publicado: (2021)

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers
por: Vasilevskaya, Anna, et al.
Publicado: (2020)

The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
por: Alster, Piotr, et al.
Publicado: (2021)

The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)
por: Swallow, Diane M. A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sok27coq6s8veeen89su30hger